Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Sanara MedTech (SMTI) Net Margin (2016 - 2025)

Sanara MedTech's Net Margin history spans 15 years, with the latest figure at 1.83% for Q4 2025.

  • For Q4 2025, Net Margin rose 819.0% year-over-year to 1.83%; the TTM value through Dec 2025 reached 35.84%, down 2662.0%, while the annual FY2025 figure was 36.05%, 2685.0% down from the prior year.
  • Net Margin reached 1.83% in Q4 2025 per SMTI's latest filing, up from 118.66% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 0.11% in Q3 2024 to a low of 118.66% in Q3 2025.
  • Average Net Margin over 5 years is 22.34%, with a median of 13.16% recorded in 2023.
  • Peak YoY movement for Net Margin: surged 3223bps in 2023, then tumbled -11855bps in 2025.
  • A 5-year view of Net Margin shows it stood at 50.45% in 2021, then skyrocketed by 46bps to 27.18% in 2022, then surged by 95bps to 1.48% in 2023, then crashed by -575bps to 10.02% in 2024, then skyrocketed by 82bps to 1.83% in 2025.
  • Per Business Quant, the three most recent readings for SMTI's Net Margin are 1.83% (Q4 2025), 118.66% (Q3 2025), and 7.06% (Q2 2025).